Get started
Author

Suhayla Sarhan

Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research
2026 · Jun Liu, Shin-Young Park, et al. · Cytotherapy
Transforming clinical apheresis waste into a renewable source of patient-derived CD34+ hematopoietic stem cell biobank for beta-hemoglobinopathy research and therapeutic discovery
2026 · Jun Liu, Shin-Young Park, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Chronic Red Cell Exchange for the Management of Alpha Thalassemia Major Complicated by Iron Overload
2026 · Daniel Y. Chang, Sanjana B. Shah, et al. · Journal of Clinical Apheresis
It Takes a Village: Developing an Interdisciplinary Team to Deliver Gene Therapy to Adult Patients with Sickle Cell Disease and Transfusion-Dependent β Thalassemia
2026 · Kaitlen Reyes, Nancy Tang, et al. · Transplantation and Cellular Therapy
A Web‐Based Calculator for Hematopoietic Progenitor Cell Collections: App Development and Retrospective Assessment
2025 · Maxwell T. Roth, Jun Liu, et al. · Journal of Clinical Apheresis
Efficacy of motixafortide plus G-CSF versus plerixafor plus G-CSF for stem cell mobilization and collection in multiple myeloma: A single-center comparative analysis and interim Results from a prospective study in poor mobilizers
2025 · Sara Close, Jun Liu, et al. · Blood
PDF
Comparative Analysis of Motixafortide versus Plerixafor for Stem Cell Mobilization and Collection in Multiple Myeloma: A Single Center Real-World Experience
2025 · Sara Close, Jun Liu, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 6
Citation count:
H-index:
I10-index:
Year
Topic
Type